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The human placenta is a vital organ without which the mammalian fetus cannot survive. It 59 forms the interface between the mother and fetus, supplying the fetus with oxygen, nutrients, 60 excreting waste products, whilst protecting against maternal immunologic attack. The main 61 functions of the placenta can be broadly categorised into transport and metabolism, 62 protection and endocrine (Gude, et al. 2004 ). The complex architecture of the placenta, 63 bounded by the maternal aspect (basal plate) and the fetal aspect (chorionic plate), houses 64 an abundance of the fundamental functional unit of the placenta, the chorionic villus, where 65 all nutritional-waste exchange between the maternal blood and the fetal circulation occurs. 66
As well as facilitating a good maternal blood supply for nutrition-waste exchange, and 67 orchestrating endocrine mediators of pregnancy to maintain maternal physiological changes 68
for an optimal environment for fetal development, the placenta also acts to protect the fetus 69 from xenobiotic materials and infectious agents (Gude et al. 2004 ; Moore, et al. 1999 ; 70 Rudge, et al. 2009; Yang 1997) . Successful development of the placenta involves two 71 distinct mechanisms: implantation of the blastocyst, initiated by attachment of the embryo to 72 the maternal endometrial epithelium, and invasion of fetal trophoblast cells into the maternal 73 endometrium to facilitate maternal-fetal exchange of nutrients, gases and waste. The diverse 74 mechanisms associated with the regulation of trophoblast invasion have been well 75 documented (Menkhorst, et al. 2016 ). The aim of the current review is to provide an 76 overview of these early events in placental development, with particular emphasis on the 77 potential role of vitamin D as a determinant of early placental development through effects 78 on trophoblast cells, particularly via effects of vitamin D on trophoblast invasion. 79 80 Vitamin D and pregnancy 81 Despite its long-standing association with rickets and osteoporosis, vitamin D has become 82 increasingly recognized as a pluripotent regulator of biological functions above and beyond 83 its classical effects on bone and calcium homeostasis. Expression of vitamin D receptor 84 (VDR) for the active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH) 2 D), as well as the 85 1α-hydroxylase enzyme that synthesizes 1,25(OH) 2 D (CYP27B1), has been reported for 86 various tissues that can be broadly termed 'barrier sites' (Jones, et al. 1998; Townsend, et 87 al. 2005) , indicating that localized responses to vitamin D may be a key feature of these 88 tissues. Prominent amongst these barrier sites is the placenta, acting as the interface 89 between mother and fetus. Historically, the placenta was one of the first extra-renal tissues 90
shown to be capable of synthesizing 1,25(OH) 2 D, with CYP27B1 activity detectable in both 91 maternal decidua and fetal trophoblast (Gray, et al. 1979; Weisman, et al. 1979 ). Initially, 92
this was linked to the rise in maternal serum 1,25(OH) 2 D that occurs at the end of the first 93 trimester of pregnancy. However, studies of CYP27B1-deficient animals and an anephric 94 pregnant woman indicated that this is not likely to be the case (Kovacs and Kronenberg 95 1997) . Instead, the presence of VDR in the placenta suggests that vitamin D functions in 96 tissue-specific fashion at the fetal-maternal interface (Bruns and Bruns 1983). One possible 97 explanation is that 1,25(OH) 2 D acts as a regulator of placental calcium transport (Bruns and 98 Bruns 1983), but a placental immunomodulatory function has also been proposed (Liu and 99
Hewison 2012). Moreover, the rapid induction of VDR and CYP27B1 early in pregnancy 100 (Zehnder, et al. 2002) suggests that vitamin D may play a more fundamental role in the 101 process of conception, implantation and development of the placenta itself. 102
103

Vitamin D and implantation 104
To date the precise role of vitamin D in the process of implantation remains unclear. 105
Nevertheless, vitamin D has a biologically plausible role in female reproduction and 106 and fertility in female rats. Female rats fed with a vitamin D-deficient diet are capable of 112 reproduction, but overall fertility is reduced including the failure of implantation (Halloran and 113 DeLuca 1980) . This was shown to be corrected by administration of 1,25(OH) 2 D (Kwiecinksi, 114 et al. 1989 ), but also by use of diets high in calcium, phosphate and lactose (Johnson and 115 DeLuca 2002), suggesting that the fertility effects of vitamin D may be due to indirect effects 116 on mineral homeostasis. Other studies using knockout mouse models have further 117 highlighted the importance of the vitamin D metabolic and signalling system in the process of 118 implantation, with Vdr -/-and Cyp27b1 -/-female mice both presenting with uterine 119 hypoplasia and infertility (Panda, et al. 2001; Yoshizawa, et al. 1997 ). Conversely, injection 120 of 1,25(OH) 2 D has been shown to increase uterine weight and promote endometrial to 121 decidual differentiation (Halhali, et al. 1991) . suggesting that this may be due to epigenetic suppression of VDR in these cells 159 (Pospechova et al. 2009 ). Further studies to assess the impact of differentiation of cultured 160 trophoblast cells have been carried out using cyclic AMP (cAMP) to mimic the process of 161 syncytialisation (Keryer, et al. 1998 ). Expression of hCG is elevated by cAMP in trophoblast 162 cells, and this was associated with decreased expression of CYP27B1, with VDR expression 163 being unaffected (Avila, et al. 2007 ), suggesting that presence of the vitamin D metabolic 164 and signalling pathways in the placenta is differentiation-sensitive. The JEG-3 trophoblast 165 cell line has also been reported to express CYP27B1, but synthesis of 1,25(OH) 2 D by these 166 cells appears to be significantly less than observed with primary trophoblast cells and 167 unaffected by cAMP (Pospechova et al. 2009 ). In addition to cAMP, inflammatory cytokines 168 The impact of vitamin D status on early events in pregnancy has also been studied. In 321 northern countries, where there is a strong seasonal contrast in light exposure and UVB-322 induced vitamin D production in skin, conception rates are decreased during winter months, 323 with rates rising during summer and an increased birth rate in spring (Rojansky, et al. 1992) . 324
Interestingly, ovulation rates and endometrial receptivity also appear to be reduced during 325 long dark winters in northern countries (Rojansky, et al. 2000) , which may be explained in 326 part by seasonal variations in vitamin D levels. With this in mind, several observational 327 studies have investigated the potential impact of vitamin D on in vitro fertilisation (IVF), albeit 328 with largely conflicting outcomes. In a study of infertile women undergoing IVF, those with 329 higher levels of 25(OH)D in serum and follicular fluid, were more likely to achieve pregnancy 330 following IVF, and high vitamin D levels were also shown to improve the parameters of This was supported by ex vivo analyses showing that 1,25(OH) 2 D is able to suppress 347 inflammatory cytokine production by endometrial cells from women with unexplained 348 recurrent spontaneous abortions (Tavakoli, et al. 2011 ). More recently, 1,25(OH) 2 D has 349 been shown to potently regulate natural killer cells from women with recurrent miscarriage 350 (Ota, et al. 2015) . Considering these observations, the impact of maternal vitamin D status 351 on pregnancy outcome has been studied in several cohorts. In a large prospective cohort 352 study of 1683 pregnant women donating serum before gestational week 22, serum 353 concentrations of 25(OH)D less than 50 nM were associated with a >2-fold increase in first 354 miscarriage rate, although no significant effect was observed for second trimester 355 miscarriage (Andersen, et al. 2015) . In a prospective study of pre-conceptual vitamin D, 356 maternal serum 25(OH)D levels were not found to be associated with chances of conceiving 357 or overall risk of miscarriage (Moller, et al. 2012 ). However, women with miscarriage in the 358 second trimester had lower first trimester serum concentrations of 25(OH)D than those women who did not miscarry (Moller et al. 2012) . In a much larger, nested case-control study 360 of over 5,000 women did not reveal any adverse effects of low serum 25(OH)D on 361 pregnancy outcomes (Schneuer, et al. 2014) . A recent meta-analysis and systematic review 362 concluded that vitamin D-deficiency is not associated with increased risk of spontaneous 363 recurrent abortion (Amegah, et al. 2017) . Thus, the possible impact of sub-optimal vitamin D 364 on implantation and adverse pregnancy outcomes such as miscarriage still remains unclear. 365
Interestingly, in endometrial tissue from women with unexplained recurrent spontaneous 366 abortion, expression of key components in the vitamin D metabolic (CYP27B1/CYP24A1) 367 and signalling (VDR) systems was found to be comparable to endometrial tissue from 368 healthy fertile women (Tavakoli, et al. 2015) . By contrast, recent studies of women with 369 recurrent miscarriage showed that expression of mRNA and protein for CYP27B1 in villous 370 and decidual tissue was lower than in control tissues from normal healthy pregnancies 371 . In future studies it will be important to clarify how variations in the 372 vitamin D system within the placenta and fetal trophoblast cells affect implantation and the 373 maintenance of a successful healthy pregnancy. focus on later stages of pregnancy, and associated adverse events such as preterm birth, 398 gestational diabetes and preeclampsia. Likewise, supplementation trials for vitamin D in 399 pregnancy have focused on women between 10 and 18 weeks of pregnancy. However, the 400 responsiveness of trophoblast cells to 1,25(OH) 2 D, notably effects on EVT invasion, 401
suggests that further studies of vitamin D and adverse events in early pregnancy are 402 required. To date there have been a limited number of reports of vitamin D-deficiency and 403 miscarriage, but these need to be expanded to include more rigorous supplementation trials. 404
The review we present is supportive of early, pre-conceptual, supplementation with vitamin 405
D. 406
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Decidua basalis (including inflammatory cells)
Expresses CYP27B1, VDR, CYP24A1 Vitamin D regulates key target genes associated with implantation, promotes immunosuppression, and induces decidualisation
Myometrium (including inflammatory cells) Expresses VDR Vitamin D regulates myometrial contractile profile, and myometrial cell proliferation
Intervillous spacematernal blood
Invasive extra-villous trophoblast (EVT)
Expresses DBP, CYP24A1, VDR, extracellular fibronectin. Vitamin D promotes EVT invasion and anti-bacterial/ anti-inflammatory responses Syncytiotrophoblast Expresses CYP27B1, VDR, CYP24A1 Vitamin D promotes antiinflammatory and anti-migratory function, and regulates production of hCG, hPL, estradiol and progesterone 
